Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 26, 2023

Comparative Effectiveness and Safety of DOACs vs Warfarin in Patients With AF and Chronic Liver Disease



Additional Info

Disclosure statements are available on the authors' profiles:

Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study
Circulation 2023 Feb 10;[EPub Ahead of Print], OD Lawal, HD Aronow, F Shobayo, AL Hume, TH Taveira, KL Matson, Y Zhang, X Wen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading